Cart
sales@molnova.com
Imitrodast
CAS No. 114686-12-3
Imitrodast( —— )
Catalog No. M36182 CAS No. 114686-12-3
Imitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 319 | Get Quote |
|
| 5MG | 513 | Get Quote |
|
| 10MG | 740 | Get Quote |
|
| 25MG | 1086 | Get Quote |
|
| 50MG | 1490 | Get Quote |
|
| 100MG | 1962 | Get Quote |
|
| 500MG | 3933 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameImitrodast
-
NoteResearch use only, not for human use.
-
Brief DescriptionImitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.
-
DescriptionImitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetThrombin
-
RecptorThrombin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114686-12-3
-
Formula Weight260.31
-
Molecular FormulaC13H12N2O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C=1SC2=C(C1)CCC(C(O)=O)=C2)N3C=CN=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Pirodomast
Pirodomast is a thromboxane A (TXA2) synthase inhibitor.
-
AZD-0837
AZD-0837 is a novel oral anticoagulant that after bioconversion to its active form is a potent and reversible thrombin inhibitor.
-
Naroparcil
Naroparcil, an orally available thioglycoside analog of 4-methylumbelliferyl β-D-xyloside, showed antithrombotic effects in the Wessler sludge model of venous thrombosis (jugular vein).
